In vivo inhibition of platelet aggregation and occlusive coronary thrombus formation by a new calcium antagonist (R023-6152).

PubWeight™: 0.75‹?›

🔗 View Article (PMID 1724526)

Published in J Cardiovasc Pharmacol on October 01, 1991

Authors

L A Sordahl1, K A Rex, C R Benedict

Author Affiliations

1: Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston 77550.

Articles by these authors

Carbon isotope discrimination in a plant possessing the C4 dicarboxylic acid pathway. Biochem Biophys Res Commun (1970) 2.82

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation (1994) 2.61

Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels. J Pharmacol Exp Ther (2000) 2.47

Local effect of serotonin released during coronary angioplasty. N Engl J Med (1994) 1.81

Photosynthetic rate of a virescent cotton mutant lacking chloroplast grana. Plant Physiol (1970) 1.75

The carboxylation of phosphoenolpyruvate and pyruvate. I. The active species of "CO2" utilized by phosphoenolpyruvate carboxykinase, carboxytransphosphorylase, and pyruvate carboxylase. J Biol Chem (1968) 1.74

Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg (1996) 1.74

Enzymic Fractionation of the Stable Carbon Isotopes of Carbon Dioxide by Ribulose-1,5-bisphosphate Carboxylase. Plant Physiol (1979) 1.41

Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. Circulation (1986) 1.35

Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage. Q J Med (1978) 1.34

Assessment of sympathetic overactivity in tetanus. Br Med J (1977) 1.34

Properties of farnesyl pyrophosphate synthetase of pig liver. Arch Biochem Biophys (1965) 1.26

Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation (1994) 1.22

A sensitive radioenzymatic assay for adrenaline and noradrenaline in plasma. Br J Clin Pharmacol (1977) 1.17

Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells. Circulation (2001) 1.12

Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology. Circulation (1989) 1.10

Plasma adrenaline and noradrenaline concentrations and dopamine-beta-hydroxylase activity in myocardial infarction with and without cardiogenic shock. Br Heart J (1979) 1.10

cis-Polyisoprene Synthesis in Guayule Plants (Parthenium argentatum Gray) Exposed to Low, Nonfreezing Temperatures. Plant Physiol (1984) 1.07

Effects of dopamine beta-hydroxylase inhibition with nepicastat on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure. Circulation (2000) 1.06

Acetate and bicarbonate metabolism in photosynthetic bacteria. Plant Physiol (1965) 1.03

Plasma catecholamines and the pressor response to Sar1-Ala8-angiotensin II in man. Clin Sci Mol Med (1977) 1.01

The development of isocitric lyase activity in germinating cotton seed. Plant Physiol (1974) 1.00

Mitogenic effect of serotonin on vascular endothelial cells. Circulation (1994) 1.00

Influence of dietary fish oil on mitochondrial function and response to ischemia. Am J Physiol (1992) 0.99

Fractionation of stable carbon isotopes by phosphoenolpyruvate carboxylase from c(4) plants. Plant Physiol (1977) 0.98

Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis. Circulation (1997) 0.96

Cholesterol flux between cells and high density lipoprotein. Lack of relationship to specific binding of the lipoprotein to the cell surface. J Biol Chem (1987) 0.96

Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation (1999) 0.96

ATP-sensitive Na(+)-H+ antiport in type II alveolar epithelial cells. Am J Physiol (1991) 0.95

Monocyte chemotactic protein 1 amplifies serotonin-induced vascular smooth muscle cell proliferation. J Vasc Res (2001) 0.94

Catecholamines in peripheral venous plasma in patients on chronic haemodialysis. Clin Sci Mol Med (1978) 0.93

Correlation of plasma serotonin changes with platelet aggregation in an in vivo dog model of spontaneous occlusive coronary thrombus formation. Circ Res (1986) 0.93

Development of ribulose 1,5-diphosphate carboxylase in nonphotosynthetic endosperms of germinating castor beans. Plant Physiol (1976) 0.92

Changes in plasma noradrenaline concentration as a measure of release rate. Br J Pharmacol (1978) 0.91

Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation. Circulation (1997) 0.90

Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis. J Mol Cell Cardiol (1991) 0.89

Mevalonic acid kinase in Euglena gracilis. Plant Physiol (1967) 0.89

Angina pectoris and sudden death in the absence of atherosclerosis following ergotamine therapy for migraine. Am J Med (1979) 0.89

Lipid peroxidation product 4-hydroxy-2-nonenal acts synergistically with serotonin in inducing vascular smooth muscle cell proliferation. Atherosclerosis (2001) 0.88

Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor. Am J Cardiol (1994) 0.88

Relation of ventricular size and function to heart failure status and ventricular dysrhythmia in patients with severe left ventricular dysfunction. Am J Cardiol (1996) 0.87

Isopentenyl Pyrophosphate cis-1,4-Polyisoprenyl Transferase from Guayule (Parthenium argentatum Gray). Plant Physiol (1984) 0.87

Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model. Circulation (1997) 0.87

Angiotensin II and serotonin potentiate endothelin-1-induced vascular smooth muscle cell proliferation. J Hypertens (2001) 0.87

Oral dolasetron mesylate in patients receiving moderately emetogenic platinum-containing chemotherapy. Oral Dolasetron Dose Response Study Group. Cancer J Sci Am (1997) 0.87

Plasma catecholamine concentrations associated with cerebral vasospasm. J Neurol Sci (1980) 0.87

ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries. Circ Res (1992) 0.86

Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury. Proc Natl Acad Sci U S A (1991) 0.86

Radioenzymatic microassay for simultaneous estimations of dopamine, norepinephrine, and epinephrine in plasma, urine, and tissues. Clin Chem (1985) 0.86

Clinical significance of plasma adrenaline and noradrenaline concentrations in patients with subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (1978) 0.86

Sympathetic nervous system activity in patients with subarachnoid hemorrhage. Stroke (1978) 0.86

Effects of graded oxygen tension on adenosine release by renal medullary and thick ascending limb suspensions. Kidney Int (1991) 0.85

Isolated ACTH deficiency. Metabolic and endocrine studies in a 7-year-old boy. Arch Dis Child (1978) 0.84

Stimulation of Isopentenyl Pyrophosphate Incorporation into Polyisoprene in Extracts from Guayule Plants (Parthenium argentatum Gray) by Low Temperature and 2-(3,4-Dichlorophenoxy) Triethylamine. Plant Physiol (1989) 0.84

Plasma noradrenaline levels as a measure of noradrenaline release [proceedings]. Br J Pharmacol (1977) 0.84

A double-blind, placebo-controlled, dose-ranging safety evaluation of single-dose intravenous dolasetron in healthy male volunteers. J Clin Pharmacol (1995) 0.84

Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation. J Hypertens (2001) 0.83

Vascular smooth muscle proliferation: synergistic interaction between serotonin and low density lipoproteins. J Am Coll Cardiol (1999) 0.83

Effect of serotonin and thromboxane A2 on endothelial cell proliferation: effect of specific receptor antagonists. J Lab Clin Med (1998) 0.83

Determination of urinary and plasma dihydroxyphenylalanine by coupled-column high-performance liquid chromatography with C8 and C18 stationary phases. J Chromatogr (1984) 0.83

Home blood pressure monitoring and changes in plasma catecholamines during once or twice daily treatment with atenolol in patients with mild hypertension. Aust N Z J Med (1979) 0.82

PEP carboxykinase exchange reaction in photosynthetic bacteria. Plant Physiol (1968) 0.82

Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Oral Dolasetron Dose-Response Study Group. Cancer (1997) 0.81

Serotonin potentiates angiotensin II--induced vascular smooth muscle cell proliferation. Atherosclerosis (2001) 0.81

Mildly oxidized low-density lipoprotein acts synergistically with angiotensin II in inducing vascular smooth muscle cell proliferation. J Hypertens (2001) 0.81

Lysophosphatidylcholine and reactive oxygen species mediate the synergistic effect of mildly oxidized LDL with serotonin on vascular smooth muscle cell proliferation. Circulation (2001) 0.80

The effect of sulfur dioxide on the response of rabbits to expiratory loads. Respir Physiol (1984) 0.80

Adenosyl-methionine incorporation into the methoxylated carotenoids in chromatophores of Rhodospirillum rubrum. Plant Physiol (1965) 0.80

Cardiolipin binding a light chain from lupus-prone mice. Biochemistry (1998) 0.80

The participation of acetyl-CoA in pyruvate carboxylase. Biochem Biophys Res Commun (1966) 0.79

Novel 21-aminosteroidlike compounds prevent iron-induced free radical-mediated injury to vascular endothelial cells. J Cardiovasc Pharmacol (1995) 0.79

Changes in plasma concentration of adrenaline and noradrenaline in anaesthetized patients during sodium nitroprusside-induced hypotension. Br J Anaesth (1978) 0.79

Radioenzymatic microassay for picogram quantities of serotonin or acetylserotonin in biological fluids and tissues. Biochem Med Metab Biol (1987) 0.79

Plasma noradrenaline levels during exposure to cold [proceedings]. J Physiol (1977) 0.78

Development and Characterization of Ribulose-1,5-bisphosphate Carboxylase : Evidence Indicating a Lack of Carboxylase Function in CO(2) Fixation in Endosperm of Germinating Castor Bean Seedlings. Plant Physiol (1983) 0.78

Evidence based cardiology: prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction. BMJ (1999) 0.78

A peptide analogue of thrombin receptor-activating peptide inhibits thrombin and thrombin-receptor-activating peptide-induced vascular smooth muscle cell proliferation. J Cardiovasc Pharmacol (2001) 0.78

Synergistic interaction between thromboxane A2 and mildly oxidized low density lipoproteins on vascular smooth muscle cell proliferation. Prostaglandins Leukot Essent Fatty Acids (2000) 0.78

Regulation of pyruvate carboxylase by coenzyme A and acyl coenzyme A thio esters. Biochemistry (1968) 0.78

Multiple-dose, placebo-controlled, phase I study of oral dolasetron. Pharmacotherapy (1996) 0.78

Differential induction of 3-hydroxy-3-methylglutaryl CoA reductase in two cotton species following inoculation with Verticillium. Mol Plant Microbe Interact (1996) 0.78

Beta(2)-glycoprotein I promotes the binding of anionic phospholipid vesicles by macrophages. Arterioscler Thromb Vasc Biol (1999) 0.78

Noradrenaline release in rats during prolonged cold-stress and repeated swim-stress. Br J Pharmacol (1979) 0.78

Thromboxane A2 fails to induce proliferation of smooth muscle cells enriched with eicosapentaenoic acid and docosahexaenoic acid. Prostaglandins Leukot Essent Fatty Acids (1999) 0.77

Quantitation of adenosine, inosine and hypoxanthine in biological samples by microbore-column isocratic high-performance liquid chromatography. J Chromatogr (1991) 0.77

The influence of oral tyrosine and tryptophan feeding on plasma catecholamines in man. Am J Clin Nutr (1983) 0.77

Single-dose, placebo-controlled, phase I study of oral dolasetron. Pharmacotherapy (1996) 0.77

Serotonin-induced endothelial cell proliferation is blocked by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids (1999) 0.77

Changes in plasma catecholamines and dopamine beta-hydroxylase after corrective surgery for coarctation of the aorta. Circulation (1978) 0.77

Restenosis after coronary angioplasty. J Interv Cardiol (1993) 0.77

Endothelial cells regulate the proliferation of monocytes in vitro. Atherosclerosis (1999) 0.77

CAROTENOIDS OF RHODOMICROBIUM VANNIELII. J Bacteriol (1962) 0.77

Eicosapentaenoic acid and docosahexaenoic acid block serotonin-induced smooth muscle cell proliferation. Arterioscler Thromb Vasc Biol (1999) 0.77

RAR gamma agonists inhibit proliferation of vascular smooth muscle cells. J Cardiovasc Pharmacol (2000) 0.76

Biosynthesis of Starch in Proplastids of Germinating Ricinus communis Endosperm Tissue. Plant Physiol (1982) 0.76

Vascular smooth muscle cells preloaded with eicosapentaenoic acid and docosahexaenoic acid fail to respond to serotonin stimulation. Atherosclerosis (2000) 0.76

Postnatal changes in heart mitochondrial calcium and energy metabolism. Am J Physiol (1991) 0.76

Inhibition of arterial thrombosis by a peptide ligand of the thrombin receptor. Thromb Res (2000) 0.76

Effects of nisoldipine therapy on myocardial perfusion and neuro-hormonal status in patients with severe ischaemic left ventricular dysfunction. Eur Heart J (1994) 0.75